• Policy
• 17 drugs receive essential medicine designations
• by Lee, Hye-Kyung Dec 3, 2024 05:53am

• Company
• 4 out of 5 pharmas saw export sales expanded
• by Kim, Jin-Gu Dec 3, 2024 05:53am

• Policy
• Janssen’s Tremfya’s price cut 2yrs due to increased use
• by Lee, Tak-Sun Dec 3, 2024 05:52am

• Company
• Reasonable compromise between industry-govt is key
• by Eo, Yun-Ho Dec 3, 2024 05:52am

• InterView
• ‘3 IBD treatment trends…early treatment is the first’
• by Kim, Jin-Gu Dec 2, 2024 05:49am

• Company
• Promotion of new drugs·biosimilars at KOS annual conference
• by Son, Hyung Min Dec 2, 2024 05:49am

• Company
• Antibody drug 'Fasenra' lands in KOR with EGPA indication
• by Eo, Yun-Ho Dec 2, 2024 05:49am

• Company
• Industry speeds up the development of bispecific antibodies
• by Son, Hyung Min Dec 2, 2024 05:49am

• Company
• Is RWD needed for post-listing control of PE exempt drugs?
• by Eo, Yun-Ho Dec 2, 2024 05:49am

• Company
• oHCM drug 'Camzyos' gets greenlight for reimb
• by Eo, Yun-Ho Nov 29, 2024 05:55am